Controlled Substance Prescribing for PMHNPs in Telehealth Setting

Prescribing a controlled substance without meeting DEA telehealth requirements is not a billing error, IT IS a federal crime. Do you know which requirements apply to your practice right now?

"Your DEA number is as important to your professional identity as your nursing license. Every controlled substance prescription is a federal act"

Written from the QM and compliance perspective, this guide tells you what QM Nurse and regulators look for, what gets flagged, and what documentation is required before, during, and after every controlled substance prescription.

This Guide Is For You If:

•   You prescribe stimulants, benzodiazepines, buprenorphine, or other controlled substances via telehealth

•   You work for or have worked for a telehealth ADHD or psychiatry platform

•   You have received a DEA correspondence, a PDMP inquiry, or a prescribing complaint

•   You ARE unsure whether your current telehealth CS prescribing meets post-PHE DEA requirements

•   You want a step by step documentation framework for every controlled substance prescription

❌ This Is NOT:

•   This is not a pharmacology reference, it covers compliance, documentation, and legal requirements only.

📋 What's Inside

CH 1 DEA Registration & Telehealth Authority

DEA registration requirements, multi-state prescribing, and the Special Telemedicine Registration explained.

CH 2 The Ryan Haight Act

What it requires, current status after the PHE, and what documentation is legally required for every telehealth CS prescription.

CH 3 Controlled Substance Schedules

Schedule II-V reference for psychiatric prescribers what psych NPs prescribe and the rules for each schedule.

CH 4 PDMP Requirements

State by state PDMP requirements, what findings must be documented, and why an undocumented PDMP query is as bad as no query.

CH 5 Stimulants & ADHD Medications

The highest-risk category complete documentation requirements, monitoring protocols, and the red flags that trigger DEA investigation.

CH 6 Benzodiazepines & Sedative-Hypnotics

Prescribing protocols, co-prescribing opioid risk documentation, liver function monitoring, and the chronic prescribing documentation trap.

CH 7 Buprenorphine & MOUD

Post-MAT Act requirements, baseline documentation, ongoing monitoring, and UDS interpretation standards.

CH 8 Antipsychotics with CS Overlap

When antipsychotic prescribing intersects with controlled substance compliance  including the clozapine REMS absolute requirement.

CH 9 Mood Stabilizers Overview

Documentation and monitoring overview for lithium, valproate, carbamazepine, and lamotrigine

CH 10 CS Documentation Requirements

The complete documentation framework for every controlled substance prescription issued via telehealth.

CH 11 Audit Red Flags & License Triggers

10-item red flag table with DEA and board consequences and criminal exposure explained.

CH 12 Prescribing Compliance Checklist

17-item controlled substance prescribing checklist  apply before issuing any CS prescription.